Video

Dr. Eure on BPH medications and increased risk of heart failure

Author(s):

Urology Times staff

Gregg Eure, MD, FACS, Urology of Virginia, discusses the increased of heart failure associated with medications for the treatment of patients with benign prostatic hyperplasia (BPH). A recently published study showed an increased risk of cardiac failure in men with BPH and exposure to 5-alpha reductase inhibitors and/or α-blockers.

Related Videos
Ravi Munver, MD, answers a question during a Zoom video interview
Raevti Bole, MD, answers a question during a video interview
Illustration of Benign Prostatic Hyperplasia | Image Credit: © Judith - stock.adobe.com
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
Ravi Munver, MD, answers a question during a Zoom video interview
Man talking with doctor, who is taking notes on a clipboard | Image Credit: © DragonImages - stock.adobe.com
Ravi Munver, MD, answers a question during a Zoom video interview
Related Content
Phase 1/2 trial launches of Focal One robotic HIFU for BPH
October 9th 2024

Phase 1/2 trial launches of Focal One robotic HIFU for BPH

Hannah Clarke
“While there are other treatment options available for treating BPH, there remains a significant need for much less invasive treatment approaches that can preserve and protect the integrity of the urethra and other critical structures," says Ryan Rhodes.
male patient sitting in clinic room while doctor talks with him
May 23rd 2023

Dr. Gange discusses data on the UroLift System for BPH

Urology Times staff
The data were presented at the recent American Urological Association Annual Meeting.
FDA grants 510(k) clearance to AI-powered robotic system for Aquablation therapy
August 21st 2024

FDA grants 510(k) clearance to AI-powered robotic system for Aquablation therapy

Hannah Clarke
A full market release of the HYDROS System is expected within the current quarter.
Destigmatizing Urology: Dr. McVary discusses enlarged prostates
February 8th 2022

Destigmatizing Urology: Dr. McVary discusses enlarged prostates

Urology Times staff
“Even though there [are] many therapies that one can do, it's not a sign of anything ominous for most men,” says Kevin T. McVary, MD, FACS.
Aquablation granted new category I CPT code for BPH management
June 18th 2024

Aquablation granted new category I CPT code for BPH management

Hannah Clarke
The new Category I code will become effective on January 1, 2026.
Senior man talking with doctor | Image Credit: © DragonImages - stock.adobe.com
June 6th 2024

Dr. Sterling and Dr. Friel describe initial experience, patient selection for Aquablation for BPH

Urology Times staff
"From a learning curve standpoint, there's not much to learn. It tends to be fairly quick in terms of your ability to do the procedure," says Matthew E. Sterling, MD.
© 2024 MJH Life Sciences

All rights reserved.